Biomea Fusion BMEA
NASDAQ BMEA
$1.76 +0.05 (+2.92%)
As of: Sep 22, 2026 · 11:19 AM EDT

Biomea Fusion (BMEA) Amortizatization of Intangibles (2021 - 2025)

Biomea Fusion's (BMEA) quarterly Amortizatization of Intangibles came in at $173000.0 in Q4 2025, down 76.68% year-over-year from $742000.0 in Q4 2024, and up 47.86% quarter-over-quarter from $117000.0 in Q3 2025.

Analysis

Biomea Fusion (BMEA) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends

Biomea Fusion has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $173000.0 for Q4 2025.

  • In Q4 2025, Amortizatization of Intangibles fell 76.68% year-over-year to $173000.0; the TTM figure through Dec 2025 stood at $1.8 million (down 34.92% YoY), while the FY2025 annual figure was $1.8 million, down 34.92% from the prior year.
  • Amortizatization of Intangibles came in at $173000.0 for Q4 2025 at Biomea Fusion, up from $117000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $999000.0 in Q1 2024 to a low of $81000.0 in Q1 2021.
  • Average Amortizatization of Intangibles over 5 years is $432300.0, with a median of $338500.0 recorded in 2021.
  • Year-over-year, Amortizatization of Intangibles jumped 389.66% in 2023 and tumbled 83.75% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $138000.0 in 2021, then rose by 5.07% to $145000.0 in 2022, then jumped by 389.66% to $710000.0 in 2023, then rose by 4.51% to $742000.0 in 2024, then slumped by 76.68% to $173000.0 in 2025.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $173000.0 in Q4 2025, $117000.0 in Q3 2025, and $791000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 984.00 Mn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - 4.33 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Biomea Fusion 132.65 Mn 132.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 173,000.00
Sep 30, 2025 117,000.00
Jun 30, 2025 791,000.00
Mar 31, 2025 766,000.00
Dec 31, 2024 742,000.00
Sep 30, 2024 720,000.00
Jun 30, 2024 377,000.00
Mar 31, 2024 999,000.00
Dec 31, 2023 710,000.00
Sep 30, 2023 691,000.00
Jun 30, 2023 673,000.00
Mar 31, 2023 612,000.00
Dec 31, 2022 145,000.00
Sep 30, 2022 144,000.00
Jun 30, 2022 142,000.00
Mar 31, 2022 140,000.00
Dec 31, 2021 138,000.00
Sep 30, 2021 185,000.00
Jun 30, 2021 300,000.00
Mar 31, 2021 81,000.00
API Access

Biomea Fusion Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=BMEA&period=max&api_key=YOUR_API_KEY